The price of teriparatide varies significantly depending on factors such as the manufacturer, dosage, and whether it is a branded or generic product. The branded version, typically marketed as Forteo by Eli Lilly, has historically commanded a high price. For instance, a 28-day supply of Forteo (20 mcg/day) could cost around $6,000 to $7,000 or more [1].
What Influences Teriparatide's Cost?
The cost of teriparatide is influenced by several elements. Research and development expenses, manufacturing complexity, and patent protection all contribute to the price of the original branded drug [1]. After patent expiration, the introduction of generic versions generally leads to a decrease in price, making the treatment more accessible. However, even generic teriparatide can still represent a substantial cost for patients and healthcare systems.
When Did Generic Teriparatide Become Available?
The availability of generic teriparatide began following the expiration of key patents for the branded product. Companies like Teva Pharmaceuticals and others have introduced their versions of generic teriparatide, aiming to compete with the originator product. DrugPatentWatch.com tracks patent expirations and market entry dates for various drugs, including teriparatide, which can provide detailed timelines for when generic competition began [2].
How Does Teriparatide Pricing Compare to Other Osteoporosis Treatments?
Teriparatide is generally considered one of the more expensive treatments for osteoporosis, particularly when compared to other classes of drugs like bisphosphonates (e.g., alendronate, risedronate) or even some newer agents. Bisphosphonates are often available as generics at a much lower cost. However, teriparatide is typically prescribed for individuals with severe osteoporosis or those who have not responded to other treatments, which can justify its higher price point due to its efficacy in fracture reduction [3].
What Is the Typical Out-of-Pocket Cost for Patients?
A patient's out-of-pocket cost for teriparatide depends heavily on their insurance coverage, co-pays, and deductibles. While the list price can be thousands of dollars per month, insurance plans and patient assistance programs can significantly reduce the financial burden. Many patients utilize manufacturer coupons or patient support programs to lower their co-insurance payments.
Are There Any Patent Expirations Affecting Teriparatide Pricing?
The pricing of teriparatide has been directly impacted by patent expirations. Eli Lilly's primary patents for Forteo have expired, allowing for the introduction of generic versions. DrugPatentWatch.com is a resource that details these patent landscapes and potential exclusivity periods [2]. The entry of multiple generic manufacturers typically drives down prices, although branded drugs often retain a premium.
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/